Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase

Bulletin Express

01/19

Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.

Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.

Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.

The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1170238152"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170238152\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170238152?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170238152","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.</p>\n<p>Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.</p>\n<p>Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.</p>\n<p>The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-01-19 20:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.</p>\n<p>Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.</p>\n<p>Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.</p>\n<p>The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣藥業","start_time":0,"source_url":"","article_id":"1170238152","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170238152","pubTimestamp":1768826554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业(01681)公布股份发行及购回更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.\nBetween 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.\nAdditionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.\nThe announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}